Question · asked by 1 review
Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser: Rise in pulse rate (% baseline)
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Multiple treatment of beta₂‐agonist via spacer (chamber) vs nebuliser Rise in pulse rate (% baseline) · children with acute asthma Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma (2013) · Cochrane Headline outcomes only | no estimate extracted | 9 studies · 670 participants | Moderate |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Holding chambers (spacers) versus nebulisers for beta‐agonist treatment of acute asthma 2013 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.